These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 23562050)

  • 61. An E. coli-produced single-chain variable fragment (scFv) targeting hepatitis B virus surface protein potently inhibited virion secretion.
    Li C; Wang Y; Liu T; Niklasch M; Qiao K; Durand S; Chen L; Liang M; Baumert TF; Tong S; Nassal M; Wen YM; Wang YX
    Antiviral Res; 2019 Feb; 162():118-129. PubMed ID: 30599174
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular basis of the interaction between proapoptotic truncated BID (tBID) protein and mitochondrial carrier homologue 2 (MTCH2) protein: key players in mitochondrial death pathway.
    Katz C; Zaltsman-Amir Y; Mostizky Y; Kollet N; Gross A; Friedler A
    J Biol Chem; 2012 Apr; 287(18):15016-23. PubMed ID: 22416135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Enhanced binding to and killing of hepatocellular carcinoma cells in vitro by melittin when linked with a novel targeting peptide screened from phage display.
    Zhao H; Feng X; Han W; Diao Y; Han D; Tian X; Gao Y; Liu S; Zhu S; Yao C; Gu J; Sun C; Lei L
    J Pept Sci; 2013 Oct; 19(10):639-50. PubMed ID: 24014474
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intracellular expression of a cloned antibody fragment interferes with hepatitis B virus surface antigen secretion.
    zu Putlitz J; Skerra A; Wands JR
    Biochem Biophys Res Commun; 1999 Feb; 255(3):785-91. PubMed ID: 10049788
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Direct modulation of HBV surface antigen in a human, HBsAg-producing hepatocellular carcinoma cell line by alpha, beta, or gamma interferons.
    Korba BE; Boumpas D; Mann D; Yoakum GH
    J Med Virol; 1990 Aug; 31(4):272-6. PubMed ID: 2176672
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Internalization of CD239 highly expressed in breast cancer cells: a potential antigen for antibody-drug conjugates.
    Kikkawa Y; Enomoto-Okawa Y; Fujiyama A; Fukuhara T; Harashima N; Sugawara Y; Negishi Y; Katagiri F; Hozumi K; Nomizu M; Ito Y
    Sci Rep; 2018 Apr; 8(1):6612. PubMed ID: 29700410
    [TBL] [Abstract][Full Text] [Related]  

  • 67. An optimized conditional suicide switch using doxycycline-dependent expression of human tBid.
    Knott A; Drueppel L; Beyer T; Garke K; Berens C; Herrmann M; Hillen W
    Cancer Biol Ther; 2005 May; 4(5):532-6. PubMed ID: 15846082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 Cells.
    Varma SR; Sundaram R; Gopumadhavan S; Vidyashankar S; Patki PS
    Hepat Res Treat; 2013; 2013():125398. PubMed ID: 23691296
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lithium effects on vesicular trafficking in hepatocellular carcinoma cells.
    Taskaeva I; Bgatova N; Gogaeva I
    Ultrastruct Pathol; 2019; 43(6):301-311. PubMed ID: 31826700
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Lu J; Collins P; Lee KJ; Li CM; Wang S
    Ann Transl Med; 2021 Nov; 9(22):1641. PubMed ID: 34988150
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Expression of modified humanized immunoapoptotic protein and its specific killing effect on HER2-positive tumor cells].
    Yang T; Zhang Y; Chen Y; Wang P; Zhao J; Yang A; Yan B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Dec; 35(12):1109-1114. PubMed ID: 31894010
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A HA2-Fusion tag limits the endosomal release of its protein cargo despite causing endosomal lysis.
    Lee YJ; Johnson G; Peltier GC; Pellois JP
    Biochim Biophys Acta; 2011 Aug; 1810(8):752-8. PubMed ID: 21664431
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chimeric RNA-binding protein-based killing switch targeting hepatocellular carcinoma cells.
    Yang J; Ding S
    Mol Ther Nucleic Acids; 2021 Sep; 25():683-695. PubMed ID: 34589286
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endosialin-positive CAFs promote hepatocellular carcinoma progression by suppressing CD8
    Gan L; Lu T; Lu Y; Song H; Zhang J; Zhang K; Lu S; Wu X; Nie F; Di S; Han D; Yang F; Qin W; Wen W
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39260826
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fusion of apoptosis-related protein Cytochrome c with anti-HER-2 single-chain antibody targets the suppression of HER-2+ breast cancer.
    Lu D; Guo Y; Hu Y; Wang M; Li C; Gangrade A; Chen J; Zheng Z; Guo J
    J Cell Mol Med; 2021 Nov; 25(22):10638-10649. PubMed ID: 34697906
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Syngeneic homograft of framework regions enhances the affinity of the mouse anti-human epidermal receptor 2 single-chain antibody e23sFv.
    Ou-Yang Q; Ren JL; Yan B; Feng JN; Yang AG; Zhao J
    Exp Ther Med; 2021 Feb; 21(2):136. PubMed ID: 33456503
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combination treatment including targeted therapy for advanced hepatocellular carcinoma.
    Lin J; Wu L; Bai X; Xie Y; Wang A; Zhang H; Yang X; Wan X; Lu X; Sang X; Zhao H
    Oncotarget; 2016 Oct; 7(43):71036-71051. PubMed ID: 27626176
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Potent killing of HBV-related hepatocellular carcinoma by a chimeric protein of anti-HBsAg single-chain antibody and truncated Bid.
    Yan B; Ouyang Q; Zhao Z; Cao F; Wang T; Jia X; Meng Y; Jiang S; Liu J; Chen R; Jia L; Zhang R; Wen W; Jin B; Chen S; Zhao J; Yang A
    Biomaterials; 2013 Jul; 34(20):4880-9. PubMed ID: 23562050
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selective cytotoxicity to HER2-positive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence.
    Wang F; Ren J; Qiu XC; Wang LF; Zhu Q; Zhang YQ; Huan Y; Meng YL; Yao LB; Chen SY; Xu YM; Yang AG
    Clin Cancer Res; 2010 Apr; 16(8):2284-94. PubMed ID: 20371697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoproapoptotic molecule scFv-Fdt-tBid modified mesenchymal stem cells for prostate cancer dual-targeted therapy.
    Yan F; Li X; Li N; Zhang R; Wang Q; Ru Y; Hao X; Ni J; Wang H; Wu G
    Cancer Lett; 2017 Aug; 402():32-42. PubMed ID: 28529067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.